155 related articles for article (PubMed ID: 28376566)
1. The association of histologic grade with acute graft-versus-host disease response and outcomes.
Narkhede M; Rybicki L; Abounader D; Bolwell B; Dean R; Gerds AT; Hanna R; Hill B; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS; Ky Hamilton B
Am J Hematol; 2017 Jul; 92(7):683-688. PubMed ID: 28376566
[TBL] [Abstract][Full Text] [Related]
2. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
3. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
5. Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant.
Nakane T; Fukuda T; Kanda J; Taniguchi S; Eto T; Ohashi K; Nakamae H; Kurokawa M; Mori T; Morishima Y; Nagamura-Inoue T; Sakamaki H; Atsuta Y; Murata M
Leuk Lymphoma; 2015; 56(8):2392-7. PubMed ID: 25629984
[TBL] [Abstract][Full Text] [Related]
6. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.
Im JS; Abraham SC; Saliba RM; Rondon G; Ross WA; Rashid A; Shpall EJ; Popat U; Qazilbash MH; Hosing C; Oran B; Shah N; Tewari P; Nieto Y; Kebriaei P; Champlin RE; Alousi AM
Am J Surg Pathol; 2017 Nov; 41(11):1483-1490. PubMed ID: 28834808
[TBL] [Abstract][Full Text] [Related]
7. Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.
Sauvestre F; Belleannée G; Bréal C; Mohr C; Fong HI; Cossin S; Tabrizi R; Milpied N; Vigouroux S; Goussot JF; Marty M
Virchows Arch; 2018 Feb; 472(2):213-220. PubMed ID: 29167990
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.
Myerson D; Steinbach G; Gooley TA; Shulman HM
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1573-1579. PubMed ID: 28533059
[TBL] [Abstract][Full Text] [Related]
9. Terminal ileum is the most sensitive site for the histologic diagnosis of grade 4 graft-versus-host disease (GvHD) in the lower GI tract and is a harbinger of poor outcome.
Yip RHL; Naso JR; Yang HM
Virchows Arch; 2021 Nov; 479(5):919-925. PubMed ID: 34131796
[TBL] [Abstract][Full Text] [Related]
10. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
11. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.
Kanda J; Morishima Y; Terakura S; Wake A; Uchida N; Takahashi S; Ono Y; Onishi Y; Kanamori H; Aotsuka N; Ozawa Y; Ogawa H; Sakura T; Ohashi K; Ichinohe T; Kato K; Atsuta Y; Teshima T; Murata M
Leukemia; 2017 Mar; 31(3):663-668. PubMed ID: 27748373
[TBL] [Abstract][Full Text] [Related]
12. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.
El-Jawahri A; Li S; Antin JH; Spitzer TR; Armand PA; Koreth J; Nikiforow S; Ballen KK; Ho VT; Alyea EP; Dey BR; McAfee SL; Glotzbecker BE; Soiffer RJ; Cutler CS; Chen YB
Biol Blood Marrow Transplant; 2016 May; 22(5):910-8. PubMed ID: 26748160
[TBL] [Abstract][Full Text] [Related]
13. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease is more prevalent and severe in the lower than the upper gastrointestinal tract.
Ma C; Maluf HM; Liu TC
Hum Pathol; 2015 Oct; 46(10):1480-7. PubMed ID: 26243672
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Hamilton BK; Rybicki L; Dean R; Majhail NS; Haddad H; Abounader D; Hanna R; Sobecks R; Duong H; Hill BT; Copelan E; Bolwell B; Kalaycio M
Am J Hematol; 2015 Feb; 90(2):144-8. PubMed ID: 25353395
[TBL] [Abstract][Full Text] [Related]
17. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.
Sorror ML; Martin PJ; Storb RF; Bhatia S; Maziarz RT; Pulsipher MA; Maris MB; Davis C; Deeg HJ; Lee SJ; Maloney DG; Sandmaier BM; Appelbaum FR; Gooley TA
Blood; 2014 Jul; 124(2):287-95. PubMed ID: 24797298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]